Individuals classified as overweight or obese, typically with a body mass index (BMI) of 30 or higher, are the best candidates for semaglutide GLP-1
Patients with diabetes will need another way to control their blood sugar and those seeking to lose weight may regain some, Hobai said
They switch medications entirely when the real issue was timing, not the compound itself
Education at every step: Youll understand precisely how the peptides support your body, helping you stay informed and confident throughout the process
Expert OpinionTrademarks Novo Nordisks Ozempic is becoming a generic term for weight-loss drugs, despite legal efforts to protect its trademark
however, changes in health behavior alone are usually unsustainable or insufficient, necessitating pharmacological therapy